RIGH

BudGenius CEO and cannabis industry notables speak to dispensary owners about legal compliance and new technologies at trade association event

Los Angeles, CA (PRWEB) June 14, 2012

BG Medical Technologies, Inc. (OTC: RIGH) and BudGenius.com, presented at yesterday’s PCA-LA event attended by Los Angeles County - Orange County dispensary operators, cannabis industry professionals, and medical marijuana patients. The event was hosted at Phototron Holdings, Inc. corporate center, an LED lighting company popular with cannabis patients and farmers.

Online medical marijuana testing laboratory BudGenius.com introduces new online features for cannabis dispensaries nationwide.

LOS ANGELES, May 24, 2012 /PRNewswire/ -- BudGenius.com, an online medical marijuana testing and laboratory system developed by BG Medical Technologies, Inc. (OTC:RIGH), has upgraded its cannabis strain management features and online services. Clients utilizing BudGenius' testing services are given a marketing edge with new online tools for more efficient strain management. BudGenius has also opened their system to all dispensaries and mobile cannabis delivery services nationwide. All cannabis professionals can now sign up for free accounts to utilize free marketing tools to improve their businesses. Clients that choose to test their medicine with BudGenius are given additional features.

Medical marijuana services leader to improve patient outreach through new marketing division

LOS ANGELES, March 29, 2012 /PRNewswire/ -- BG Medical Technologies, Inc. (OTC: RIGH), a leader in medical marijuana professional services, announces the formation of a new digital services marketing division to create best-in-class asset management for cannabis related Internet properties.

The new division is aligned to support company initiatives for monetization of high value and high traffic Internet web sites, brands, and virtual properties. The unit will implement a strong focus on demographic, behavioral, and contextual analysis to best deliver relevant content to patients and information seekers of medical cannabis treatments. This will occur across a breadth of new and existing medical marijuana brands. The division will also lay the groundwork for a cannabis-niche advertising network set for release later this year. BG Medical's consistent focus on patient interests supports industry growth rates as new states continue to ratify medical marijuana legalization. Through internal initiatives and contracts currently under negotiation, the branch is expected to produce $2.1 million in revenue of previously stated $6.5 million 2012 year end goals.

Medical marijuana technology company advances forward in building value through deployed and accessible innovations

LOS ANGELES, March 20, 2012 /PRNewswire/ -- BG Medical Technologies, Inc. (OTC: RIGH) is pleased to issue the following shareholder update on the status of current operations and a brief review of ongoing accomplishments. BG Medical Technologies continues to grow as a services leader in data collection for the medical marijuana industry while growing a broad horizontal of natural medicine and technology-related holistic healthcare solutions. The company remains proud in its differentiating position as one of the few publicly traded cannabis companies with actively deployed products and services producing revenue positive results.

BG Medical continues to grow its flagship service, BudGenius.com, a widely recognized brand of medical marijuana research, testing, and Internet technologies. The company also announces today that several high-value acquisitions are currently in progress to expand marketing influence, client accessibility, and additional revenues. Each of these proposed acquisitions leverages the company's proven track record of technical and marketing expertise without reliance on dilution or capital expenditures. The company expects to make several significant announcements prior to the closing of Q2.

LOS ANGELES, March 15, 2012 /PRNewswire/ -- BG Medical Technologies is pleased to announce the release of a new audio interview with Angel Stanz, CEO of BG Medical Technologies, Inc. (OTC: RIGH). The interview can be accessed at http://www.thestockradio.com

Mr. Stanz discusses the emergent medical marijuana industry along with technology innovations BG Medical Technologies is establishing for natural healthcare treatments. Topics covered include the importance of cannabis testing, the unique features of BG Medical's BudGenius and BudGenius.com medical cannabis testing systems, and the growing confidence of cannabis treatment nationwide. Mr. Stanz also shares his feelings regarding problems with the current healthcare system and how rising interests in alternative treatments are changing approaches to personal wellness. The discussion is capped with an exciting forward-looking vision of the role Internet technologies are expected to play in lowering the future of healthcare costs.

BudGenius' new "MenuGenius" application educates patients and reduces operational costs for medical marijuana caregivers

LOS ANGELES, March 12, 2012 /PRNewswire/ -- BudGenius.com, an online medical marijuana laboratory system developed by BG Medical Technologies, Inc. (OTC:RIGH), announces "MenuGenius", a new online tool available to all cannabis caregivers. This application is offered to all cannabis professionals that signup for a free account on the BudGenius.com system. The online medicine menu displays statistics for both tested and untested variants of marijuana medicine, and is deployable to nearly any website at no additional charge. Medical marijuana directory websites can also take advantage of the tool, as it has been developed to integrate as an add-on module into several popular content management systems, offering native search capabilities for listed strains. Directory websites can also increase their revenue through an affiliate business model for medical cannabis testing, which comes integrated with the MenuGenius software.

Cannabis Research Firm and Medical Marijuana Testing Laboratory Announces Upgrades to Comprehensive Investor Relations Website

LOS ANGELES, March 8, 2012 /PRNewswire/ -- BG Medical Technologies, Inc. (OTC:RIGH) announces newly launched investor relations components for its company website at http://www.BgMedTech.com, reflecting their ongoing efforts to provide up-to-date information for medical marijuana investors and shareholders.

These upgrades provide a comprehensive overview of BG Medical Technologies from an investment advisory perspective, including recent news releases, corporate governance, regulatory filings, stock information, charts, quotes, and additional shareholder resources.

BG Medical Technologies new location to support additional staff and planned capacity growth for laboratory services, media production, and customer support.

LOS ANGELES, March 6, 2012 /PRNewswire/ -- BG Medical Technologies, Inc. (OTC:RIGH) today announces the relocation to new corporate headquarters for accommodating its rapid growth and future expansion plans. These new facilities will provide increased capacity for medical marijuana laboratory testing, developing natural medicine solutions, media production, content creation, sales, and leadership functions across the company.

Organic medicine goes "high" tech with medical marijuana, natural herbs, and Internet technology.

LOS ANGELES, Feb. 29, 2012 /PRNewswire/ -- BG Medical Technologies, Inc. (OTC:RIGH) is set to engage an $11 billion dollar tele-healthcare market in addition to the projected $14 billion dollar medical marijuana market, with Internet and smartphone applications to support growing trends of natural medicine and wellness care.

Healthcare costs in the United States are some of the highest in the world leaving many Americans uninsured, under-insured, or living in communities without access to affordable care. This problem worsens as US healthcare costs continue to rise each year. For those who can afford healthcare, new problems are introduced. The Centers for Disease Control and Prevention report that half of all Americans will be diagnosed with a mental illness during their lifetime. Celebrity prescription drug deaths dominate media headlines, and pharmaceutical-related drug deaths now outnumber traffic fatalities in the United States.

BG Medical Technologies combines laboratory research, Internet cloud technologies, and medical diagnostics for a data-based approach to medical marijuana treatment programs.

LOS ANGELES, Feb. 27, 2012 /PRNewswire/ -- BG Medical Technologies (OTC: RIGH) has announced development of a USB-enabled diagnostic support device that will facilitate patients suffering from critical illnesses such as cancer, to match the most effective plant variants for physician-recommended medical marijuana treatments. The device will collect patient data in a non-invasive manner by detecting subtle shifts in the patient's physiology and then upload encrypted data to HIPAA-compliant servers for further analysis and physician review. Physicians will interact with patients and data history through a bundled video conferencing application. This will offer patients the ability to discreetly pursue medical marijuana treatment from the privacy of their home. For states with telemedicine restrictions, services will be made available for use within physician offices. This system also seeks to improve medical marijuana treatment programs by involving physicians more than once per year to better evaluate treatment effectiveness and applicability.

The diagnostic support system works in tandem with BG Medical's BudGenius.com laboratory research and ongoing data collection to identify marijuana strains that present the most beneficial ratios of medicinal compounds that are likely to best serve the patient's needs. Medicine locator services will also be used to locate cannabis strains currently available within the patient's travel radius. BudGenius services will continue to be expanded with new features to support the diagnostic system development, and will be further enhanced with new technology partnerships. BG Medical has stated that this announcement fulfills another component of their "natural medicine trifecta", an empirical data approach to administering natural medical marijuana treatments, as detailed in their product strategy guide.